News
IASO Bio Announces Acceptance of New Drug Application for Equecabtagene Autoleucel (FUCASO) by the Singapore Health Sciences Authority (HSA) PR Newswire SHANGHAI and NANJING, China and SAN JOSE ...
SHANGHAI and NANJING, China and SAN JOSE, Calif., Jan. 29, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing ...
SHANGHAI and NANJING, China and SAN JOSE, Calif., Jan. 29, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback